Precision Medicine in Oncology: Individualized Treatment Approaches Through Patient Profiling in Breast Cancer

Dr. Rodrigo Sanchez-Bayona and Dr. Giuseppe Curigliano reviewed recent clinical trials and treatment options for patients with CDK4/6 inhibitors, ESR1 mutations, and PI3K mutations, emphasizing the evolving landscape and the importance of personalized treatment strategies.

Target Audience

Healthcare Professionals

Learning Objectives

  • Analyze the role of molecular profiling and genetic testing in developing individualized treatment plans.
  • Integrate patient factors (such as age, comorbidities, and biomarker status) into personalized treatment decisions.
  • Understand the importance of patient selection factors and their impact on defining the best treatment alternative during the patient journey.
  • Balance multiple factors (pathological, clinical, and molecular) to optimally select the best treatment for each patient.

This activity is supported by an educational grant from Eli Lilly.

Course summary

Course opens: 
03/25/2025
Course expires: 
09/30/2031
Cost:
$0.00
Rating: 
0
Dr. Rodrigo Sánchez-Bayona,MD PhD

Dr. Rodrigo Sánchez-Bayona,MD PhD

Unidad de Cáncer de Mama y Ginecológico
Hospital 12 de Octubre
ESMO Young Oncologists Committee member

Prof. Giuseppe Curigliano

Prof. Giuseppe Curigliano

Professor of Medical Oncology at University of Milan, Italy

Price

Cost:
$0.00
Please login or register to take this course.